HN2002000193A - Compuestos heterociclicos como ligandos de los receptores gabaa - Google Patents
Compuestos heterociclicos como ligandos de los receptores gabaaInfo
- Publication number
- HN2002000193A HN2002000193A HN2002000193A HN2002000193A HN2002000193A HN 2002000193 A HN2002000193 A HN 2002000193A HN 2002000193 A HN2002000193 A HN 2002000193A HN 2002000193 A HN2002000193 A HN 2002000193A HN 2002000193 A HN2002000193 A HN 2002000193A
- Authority
- HN
- Honduras
- Prior art keywords
- gabaa
- receivers
- links
- compounds
- heterociclical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Catalysts (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA PRESENTE INVENCION SE REFISRE A COMPUESTOS HETEROCICLICOS Y MAS ESPECIFICAMENTE A AQUELLOS COMPUESTOS QUE SE ENLAZAN CON GRAN SELECTIVIDAD Y GRAN AFINIDADA AL SITIO BENZODIAZEPINA DE LOS RECEPTORES GABAA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22366900P | 2000-08-07 | 2000-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2002000193A true HN2002000193A (es) | 2002-11-05 |
Family
ID=22837525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2002000193A HN2002000193A (es) | 2000-08-07 | 2002-07-24 | Compuestos heterociclicos como ligandos de los receptores gabaa |
Country Status (18)
Country | Link |
---|---|
US (2) | US6653471B2 (es) |
EP (1) | EP1325006A2 (es) |
JP (1) | JP2004505942A (es) |
KR (1) | KR20030036678A (es) |
CN (1) | CN1468241A (es) |
AU (1) | AU2001285401A1 (es) |
BR (1) | BR0113120A (es) |
CA (1) | CA2420967A1 (es) |
CO (1) | CO5310576A1 (es) |
EC (1) | ECSP014130A (es) |
HN (1) | HN2002000193A (es) |
IL (1) | IL154310A0 (es) |
MX (1) | MXPA03001186A (es) |
PA (1) | PA8524601A1 (es) |
PE (1) | PE20020275A1 (es) |
TN (1) | TNSN01122A1 (es) |
UY (1) | UY26874A1 (es) |
WO (1) | WO2002012442A2 (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002068425A1 (en) * | 2001-02-23 | 2002-09-06 | Ortho-Mcneil Pharmaceutical, Inc. | Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
BR0307504A (pt) * | 2002-02-07 | 2004-12-07 | Neurogen Corp | Composto ou sal farmaceuticamente aceitável, composição farmacêutica, métodos tratar doenças, para potencializar um efeito terapêutico de um agente para o snc, para melhorar a memória de curto prazo em um paciente, para determinar a presença ou ausência de receptores gabaa em uma amostra, e para alterar a atividade transdutora de sinal do receptor gabaa, embalagem, e, uso de um composto ou sal |
AR045037A1 (es) | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
FR2857363B1 (fr) * | 2003-07-10 | 2007-09-07 | Aventis Pharma Sa | 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation |
EP1848430B1 (en) * | 2004-12-31 | 2017-08-02 | Dr. Reddy's Laboratories Ltd. | Novel benzylamine derivatives as cetp inhibitors |
US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
US8583926B1 (en) | 2005-09-19 | 2013-11-12 | Jpmorgan Chase Bank, N.A. | System and method for anti-phishing authentication |
WO2007053352A2 (en) * | 2005-10-28 | 2007-05-10 | Wyeth | Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
US20070099911A1 (en) * | 2005-10-28 | 2007-05-03 | Wyeth | Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands |
KR20080086917A (ko) * | 2005-12-29 | 2008-09-26 | 노파르티스 아게 | 콜레스테릴 에스테르 전달 단백질 (cetp) 억제제로서의피리디닐 아민 유도체 |
AU2007247385B2 (en) | 2006-05-10 | 2011-07-14 | Novartis Ag | Bicyclic derivatives as CETP inhibitors |
CA2650515A1 (en) * | 2006-05-11 | 2007-11-22 | Novartis Ag | Benzylamine derivatives as cetp inhibitors |
EP2086961A1 (en) * | 2006-11-15 | 2009-08-12 | Novartis AG | Heterocyclic derivatives as cetp inhibitors |
CA2728366A1 (en) * | 2007-07-03 | 2009-01-08 | Raymond Andersen | Small molecule correctors of deltaf508 cftr trafficking |
PE20140407A1 (es) | 2008-06-10 | 2014-04-25 | Abbott Lab | Nuevos compuestos triciclicos |
SG175318A1 (en) * | 2009-05-07 | 2011-11-28 | Hoffmann La Roche | Isoxazole-pyridine derivatives as gaba modulators |
TW201802091A (zh) | 2009-12-01 | 2018-01-16 | 艾伯維有限公司 | 新穎三環化合物 |
PE20130005A1 (es) | 2009-12-01 | 2013-02-16 | Abbvie Inc | Compuestos triciclicos novedosos |
CN102712640A (zh) * | 2010-01-12 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 三环杂环化合物、其组合物和应用方法 |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
BR112013033777A2 (pt) * | 2011-03-15 | 2016-09-13 | Abbvie Inc | moduladores de receptor de hormônio nuclear |
WO2013055386A2 (en) | 2011-10-03 | 2013-04-18 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
PT3176170T (pt) | 2012-06-13 | 2019-02-05 | Incyte Holdings Corp | Compostos tricíclicos substituídos como inibidores de fgfr |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
TW201422590A (zh) | 2012-09-07 | 2014-06-16 | Abbvie Inc | 雜環核激素受體調節劑 |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
WO2014094357A1 (en) | 2012-12-21 | 2014-06-26 | Abbvie Inc. | Heterocyclic nuclear hormone receptor modulators |
PE20152033A1 (es) | 2013-04-19 | 2016-01-21 | Incyte Holdings Corp | Heterociclos bicicliclos como inhibidores de fgfr |
KR101612179B1 (ko) * | 2013-04-19 | 2016-04-12 | 영남대학교 산학협력단 | 아미도피리딘올 유도체 또는 이의 약제학적 허용가능한 염을 유효성분으로 함유하는 암질환 예방 또는 치료용 약학조성물 |
WO2015125858A1 (ja) * | 2014-02-24 | 2015-08-27 | 日本曹達株式会社 | ヘテロアリール化合物およびその用途 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
EP3617205B1 (en) | 2015-02-20 | 2021-08-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
US9580423B2 (en) | 2015-02-20 | 2017-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
SG10201913986YA (en) | 2015-10-16 | 2020-03-30 | Abbvie Inc | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF |
US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11773106B2 (en) | 2015-10-16 | 2023-10-03 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
CN112867716A (zh) | 2018-05-04 | 2021-05-28 | 因赛特公司 | Fgfr抑制剂的固体形式和其制备方法 |
CA3099116A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
JOP20220083A1 (ar) | 2019-10-14 | 2023-01-30 | Incyte Corp | حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
CA3162010A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
US11891377B1 (en) | 2023-09-06 | 2024-02-06 | King Faisal University | Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206415A (en) | 1991-12-20 | 1993-04-27 | Washington University | Tricyclic steroid analogs |
US5344626A (en) * | 1992-06-26 | 1994-09-06 | Minnesota Mining And Manufacturing Company | Dual impregnated activated carbon |
US5723462A (en) | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
GB9708945D0 (en) * | 1997-05-01 | 1997-06-25 | Merck Sharp & Dohme | Therapeutic agents |
CA2288789C (en) * | 1997-05-08 | 2009-07-21 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
GB9713707D0 (en) | 1997-06-27 | 1997-09-03 | Merck Sharp & Dohme | Therapeutic agents |
AU1224499A (en) * | 1997-12-09 | 1999-06-28 | Neurosearch A/S | Chemical compounds for use as anxiolytic agents and a method for the identification of anxiolytic compounds |
AU2879799A (en) * | 1998-02-26 | 1999-09-15 | Neurogen Corporation | 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands |
US6166203A (en) | 1998-02-26 | 2000-12-26 | Neurogen Corporation | Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands |
-
2001
- 2001-08-06 EP EP01964561A patent/EP1325006A2/en not_active Withdrawn
- 2001-08-06 WO PCT/US2001/041572 patent/WO2002012442A2/en active Application Filing
- 2001-08-06 US US09/924,174 patent/US6653471B2/en not_active Expired - Fee Related
- 2001-08-06 CN CNA018169902A patent/CN1468241A/zh active Pending
- 2001-08-06 MX MXPA03001186A patent/MXPA03001186A/es active IP Right Grant
- 2001-08-06 KR KR10-2003-7001844A patent/KR20030036678A/ko not_active Application Discontinuation
- 2001-08-06 BR BR0113120-6A patent/BR0113120A/pt not_active IP Right Cessation
- 2001-08-06 CA CA002420967A patent/CA2420967A1/en not_active Abandoned
- 2001-08-06 JP JP2002517733A patent/JP2004505942A/ja active Pending
- 2001-08-06 AU AU2001285401A patent/AU2001285401A1/en not_active Abandoned
- 2001-08-06 IL IL15431001A patent/IL154310A0/xx unknown
- 2001-08-07 TN TNTNSN01122A patent/TNSN01122A1/fr unknown
- 2001-08-07 EC EC2001004130A patent/ECSP014130A/es unknown
- 2001-08-07 PE PE2001000785A patent/PE20020275A1/es not_active Application Discontinuation
- 2001-08-07 PA PA20018524601A patent/PA8524601A1/es unknown
- 2001-08-07 UY UY26874A patent/UY26874A1/es not_active Application Discontinuation
- 2001-08-08 CO CO01063854A patent/CO5310576A1/es not_active Application Discontinuation
-
2002
- 2002-07-24 HN HN2002000193A patent/HN2002000193A/es unknown
-
2003
- 2003-09-23 US US10/670,077 patent/US6949562B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TNSN01122A1 (fr) | 2005-11-10 |
PE20020275A1 (es) | 2002-04-09 |
CO5310576A1 (es) | 2003-08-29 |
EP1325006A2 (en) | 2003-07-09 |
US20030105081A1 (en) | 2003-06-05 |
MXPA03001186A (es) | 2004-04-20 |
KR20030036678A (ko) | 2003-05-09 |
IL154310A0 (en) | 2003-09-17 |
WO2002012442A2 (en) | 2002-02-14 |
PA8524601A1 (es) | 2003-09-05 |
CN1468241A (zh) | 2004-01-14 |
ECSP014130A (es) | 2002-03-25 |
BR0113120A (pt) | 2004-06-22 |
US6653471B2 (en) | 2003-11-25 |
UY26874A1 (es) | 2002-03-22 |
JP2004505942A (ja) | 2004-02-26 |
AU2001285401A1 (en) | 2002-02-18 |
US20040110778A1 (en) | 2004-06-10 |
WO2002012442A3 (en) | 2003-05-01 |
CA2420967A1 (en) | 2002-02-14 |
US6949562B2 (en) | 2005-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2002000193A (es) | Compuestos heterociclicos como ligandos de los receptores gabaa | |
HN1999000149A (es) | Derivados de 4,4-biarilpiperidina | |
CR7812A (es) | Compuestos de purina y usos de los mismos como ligandos de receptor de cannabinoides | |
HN2001000018A (es) | Carboxamidas de pirimidina utiles como inhibidores de isozimas pde4. | |
PA8600501A1 (es) | Ligandos de receptor cannabinoide y usos de los mismos | |
SV2001000004A (es) | Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa | |
UY27343A1 (es) | Ligandos del receptor de 5-ht y sus usos | |
HN1999000106A (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
UY28670A1 (es) | Arilpirazoles sustituidos | |
GT199900215A (es) | Formulaciones agroquimicas. | |
SV2002000249A (es) | Derivados de tiazolilamida ref, lea 34082-sv | |
CR8092A (es) | Pirazolopirimidinas sustituidas, procedimientos para su obtencion y el uso de las mismas para combatir hongos nocivos, asi como productos que las contienen | |
ES2167314T3 (es) | Catalizadores para eliminar compuestos de azufre de gases tecnicos, procedimiento para su preparacion y su uso. | |
SV1997000047A (es) | Antagonistas de receptor de benzoxazinona dopamina d4 | |
ES2161078T3 (es) | Reactor de lecho fluidizado y su utilizacion. | |
PA8577601A1 (es) | Derivados aldehido de polietilenglicol | |
ES2159270B1 (es) | Oleorresina de hypericum perforatum l., procedimiento de obtencion y usos. | |
ECSP077979A (es) | Potenciadores del receptor ampa | |
ES2180062T3 (es) | Derivados del acido glioxilico. | |
ES2177825T3 (es) | Procedimiento para la proteccion selectiva de los derivados de la baccatina y su utilizacion en la sintesis de taxanos. | |
HN1999000082A (es) | 3-ceto derivados triciclicos de 6-0- metileritromicina. | |
PA8462901A1 (es) | Procedimiento de sintesis de pirrol amidas | |
GT199800165A (es) | Polimorfos de dofetilida. | |
HN2002000192A (es) | Derivados benzimidazol y piridilimidazol como ligandos para gabaa. | |
PA8436301A1 (es) | Compuestos de amonio cuaternario |